In cancer survivors, wireless device will detect heart dysfunction

Scientists have designed a novel wireless device which may accurately detect heart dysfunction in children who have survived cancer.

By: Agencies | | Updated: June 23, 2018 3:13 pm

Childhood cancer survivors are advised to undergo screening for the detection of heart dysfunction because of known anthracycline-induced cardiotoxicity. Also Read - Peritoneal cancer is not only rare but can easily be confused with ovarian cancer

However, screening with echocardiography — the standard of care for monitoring heart function — can be highly variable and limited. Read: World Health Day 2018: Universal health coverage and disease burden of cancer Also Read - Common infections can be fatal if you have cancer: Know what to look out for

Another alternative is cardiac magnetic resonance (CMR) imaging, which is expensive and is not widely accessible. Also Read - Heath Tech: 4 innovative technologies that will change cancer treatment

In the study, the team tested Vivio — a prototype handheld instrument which collects pulse waves and phonocardiogram data from the carotid artery. The results showed that the device was accurate and it displayed a low false-negative rate as compared to CMR imaging.

“This study is the first step in thinking about new paradigms of long-term monitoring and care delivery for cancer survivors who are at risk for severe and life-threatening health conditions,” said Saro Armenian, Director at City of Hope National Medical Centre in California.

The study, published in the journal Clinical Cancer Research, involved data from 191 patients exposed to anthracycline chemotherapy.

The data of the participants was collected using Vivio which then streamed wirelessly to a compatible device such as a smart phone or e-tablet. Read: 10 must-know facts about brain tumour or brain cancer

This mobile health platform negates the need for result interpretation and allows for real-time monitoring of heart health, explained Armenian.

Using a specialised algorithm, Vivio measures the left ventricular ejection fraction (LVEF), which is commonly used to assess heart function and measures the percentage of blood ejected from the left ventricle of the heart, Armenian added.

However, the author said that Vivio is not currently intended to replace echocardiography or CMR imaging.

“One possible implementation of Vivio could be for preliminary screening,” Armenian explained.

Source: IANS

Image Source: Shutterstock

Published : June 23, 2018 3:13 pm | Updated:June 23, 2018 3:13 pm

Read Disclaimer

Know about the drug compound that may freeze cancer cells and kill them

Bladder cancer: Robotic surgery as effective as open surgery

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com

+91 – 22 – 6697 1234

91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

We respect your privacy

Know about the drug compound that may freeze cancer cells and kill them

Bladder cancer: Robotic surgery as effective as open surgery

Peritoneal cancer is not only rare but can easily be confused with ovarian cancer

New analysis identifies 32 new risk variants for breast cancer: Know how to keep this disease at bay

Common infections can be fatal if you have cancer: Know what to look out for

Heath Tech: 4 innovative technologies that will change cancer treatment

Bring down your risk of breast cancer: Reduce milk intake

About The health Site

Useful Links